2013
DOI: 10.1186/1477-7819-11-224
|View full text |Cite
|
Sign up to set email alerts
|

Paraneoplastic stiff person syndrome associated with colon cancer misdiagnosed as idiopathic Parkinson’s disease worsened after capecitabine therapy

Abstract: ObjectivesTo refresh clinical diagnostic dilemmas in patients presenting with symptoms resembling to those of parkinsonism, to report rare association of colon cancer and paraneoplastic stiff person syndrome (SPS), and to draw attention on the possible correlation of capecitabine therapy with worsening of paraneoplastic SPS.MethodsCase report of the patient with paraneoplastic SPS due to colon cancer that was misdiagnosed as idiopathic Parkinson’s disease (iPD), whose symptoms worsened after beginning adjuvant… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
10
0
2

Year Published

2014
2014
2024
2024

Publication Types

Select...
8
1

Relationship

0
9

Authors

Journals

citations
Cited by 17 publications
(12 citation statements)
references
References 9 publications
0
10
0
2
Order By: Relevance
“…Paraneoplastic SPS is reported to usually present with breast cancer, small cell lung carcinoma, thymoma and Hodgkin's lymphoma 8. Moreover, two cases related to colorectal cancer have been reported 9 10…”
Section: Discussionmentioning
confidence: 99%
“…Paraneoplastic SPS is reported to usually present with breast cancer, small cell lung carcinoma, thymoma and Hodgkin's lymphoma 8. Moreover, two cases related to colorectal cancer have been reported 9 10…”
Section: Discussionmentioning
confidence: 99%
“…The etiology in most SPS (and SLS) cases is an autoimmune process, but in rare cases (approximately 5%) it is paraneoplastic, and fewer cases still are cryptogenic. Paraneoplastic SPS and SLS can also be associated with anti-GAD antibodies, but a majority of paraneoplastic cases are anti-GAD antibody negative [ 2 , 9 , 14 , 15 ].…”
Section: Discussionmentioning
confidence: 99%
“…Long-term symptoms, overlapping type 1 (insulin-dependent) diabetes, the presence of anti-GAD65 antibodies and the absence of anti-amphiphysin antibodies point to autoimmune SPS. Differential diagnosis in SPS should also include clinical entities and disorders such as dystonia, spasticity, tetanus, neuromyotonia and Parkinson's syndromes (Andreadou et al, 2007;Badzek et al, 2013;Baizabal-Carvallo, 2019;Rakocevic et al, 2019) as well as mental disorders with dominant anxiety symptoms (Dalakas, 2009;Henningsen et al, 1996;Ozer et al, 2009;Rakocevic et al, 2019). Additional tests and a detailed medical history allowed to exclude the above-mentioned diseases.…”
Section: Omówienie Kryteria Rozpoznania Diagnostyka Różnicowa I Leczeniementioning
confidence: 99%